Arrowhead Pharmaceuticals Inc. buy Chardan Capital
Start price
18.07.24
/
50%
€25.45
Target price
18.07.25
€54.83
Performance (%)
-13.05%
Price
23.08.24
€22.13
Summary
This prediction is currently active. The prediction for Arrowhead Pharmaceuticals Inc. disappoints with a performance of -13.05%. This prediction currently runs until 18.07.25. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arrowhead Pharmaceuticals Inc. | 7.427% | 7.427% |
iShares Core DAX® | 1.665% | 1.692% |
iShares Nasdaq 100 | -0.475% | 1.483% |
iShares Nikkei 225® | 2.620% | 4.475% |
iShares S&P 500 | -0.091% | 1.099% |
Comments by Chardan_Capital for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $60.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Chardan_Capital for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.45
18.07.24
18.07.24
€54.83
18.07.25
18.07.25
-13.05%
23.08.24
23.08.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.44
26.06.24
26.06.24
€56.18
26.06.25
26.06.25
-13.01%
23.08.24
23.08.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€22.62
03.06.24
03.06.24
€55.13
03.06.25
03.06.25
-2.17%
23.08.24
23.08.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€20.70
10.05.24
10.05.24
€55.70
10.05.25
10.05.25
6.91%
23.08.24
23.08.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.07
08.08.23
08.08.23
€54.73
08.08.24
08.08.24
-10.25%
09.08.24
09.08.24